ReS19-T

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameReS19-T

Drug Alias NameReS19-T

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMicrotubule-associated protein tau inhibitors

TargetsMicrotubule-associated protein tau

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesRemynd

China Registration ClassN/A

Active CompaniesRemynd

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

ATC CodeN/A